Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Taysha Gene Therapies (TSHA) Misses Q3 EPS by 27c

November 10, 2021 7:23 AM EST

Taysha Gene Therapies (NASDAQ: TSHA) reported Q3 EPS of ($1.35), $0.27 worse than the analyst estimate of ($1.08).

For earnings history and earnings-related data on Taysha Gene Therapies (TSHA) click here.

... More